https://www.selleckchem.com/pr....oducts/seclidemstat.
297; P =.036), serum albumin (r=-.494; P=.001), serum sodium (r=-.369; P =.008), Model for End Stage Liver Disease (MELD) score (r=.316; P =.026) and MELD-Na score (r=.470; P =.001). RARI showed no significant relationship with serum creatinine (r=.110; P =.445) and blood urea nitrogen (r=.112; P =.437). Liver cirrhosis is associated with renovascular changes which manifest as increased resistance in the renal arteries. RARI is a useful noninvasive tool for the assessment of these changes and should be done routinely in the eva
Like
Comment
Share
